-
Most Recent
Search Results
240 results for BIOF
iBio Looks Well-Positioned to Succeed
iBio reports impressive Q1 results as biotech companies see a strong rally this year. Here’s the latest on IBIO stock.
Market Analysis – Warning: Market May Cause Indigestion
If you plan to buy stocks now, you had better order a case of antacids to go along with your Wall Street Journal.
3 Medical Devices Stocks to Sell Now
This week, the overall grades of three medical devices stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”)…
iBio Is a Risky Way to Make a Short-Term Profit
IBIO stock comes with all of the risks associated with penny stocks, making it a poor long-term play but worthwhile for traders willing to put…
Why Is Baudax Bio (BXRX) Stock Up 50% Today?
BXRX stock is soaring today as Baudax Bio’s novel medical product could result in time and cost savings for patients and hospitals.
Buy iBio Stock as an Effective Vaccine Could Be Imminent
Seemingly everyone in the investing world is betting on a coronavirus vaccine. Here’s why IBIO stock is a great way to play that trend.
7 Medical Devices Stocks to Sell Now
The overall ratings of seven medical devices stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall…
Firming Financials Point to an Underappreciation of iBio Stock
The IBIO stock price is down, but that doesn’t mean the company’s in trouble. In fact, the data shows that iBio’s fiscal health is improving.
IBM Partnership and Rising Covid-19 Cases Are Lifting iBio Stock
Fears of a second coronavirus wave have Covid-19 focused biotech stocks surging again. So where does IBIO stock fit into the mix?
Right Now, iBio Stock Is Even More Risky Than You Might Have Thought
Buying a stock because it could be part of the solution to coronavirus is a risky way to play an already volatile market. IBIO stock’s…
Why Is BiomX (PHGE) Stock Up 8% Today?
BiomX (PHGE) stock is rocketing on Wednesday following the release of the company’s earnings report for the fourth quarter of 2022.
The Curtain Is Coming Down on IBIO
It appears iBio may have to settle for an assist in the race for a Covid-19 vaccine, but that gives investors little reason to buy…
iBio Stock Is Too Risky
IBIO stock gets attention because of iBio’s foray into treating the coronavirus, but investors who want that exposure should look elsewhere.
iBio Takes Swings, But Hasn’t Found a Pitch It Can Hit
There has been a lot of noise surrounding IBIO stock. But investors need that noise to turn into actionable news to reverse the stock’s trend.
iBio Is Now Lagging in Another Area
iBio’s leading vaccine and its therapy appear to be too far behind the competition to generate much revenue for IBIO stock.
Stay Away from iBio Until It Has More Than a Story
IBIO stock is rewarding investors who bet on its unique approach to a Covid-19 vaccine. But as the field narrows, iBio needs to deliver more…
BioShock Creator Irrational Games Is Shutting Down
Irrational Games, which created the best-selling BioShock video games, is shutting down so its found can concentrate on other projects.
BIOR Stock Starts Trading as Progenity’s Rebrand Takes Shape. What to Know.
Biora’s product is supposed to enable biologics to be delivered directly to GI tracts. BIOR stock is a favorite of retail investors.
3 Speculative Stocks That Are About to Get Absolutely Crushed
These three speculative stocks all rose more than 300% over the past year. They will likely end up among 2024’s largest losers.
7 – 10 of 240 results
